Teacher: In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Teacher: Now, understand the problem? If you are still confused, see the following example:
SECTION 1. LIABILITY OF BUSINESS ENTITIES PROVIDING USE OF FACILITIES
TO NONPROFIT ORGANIZATIONS.

(a) Definitions.--In this section:
(1) Business entity.--The term ''business entity'' means a
firm, corporation, association, partnership, consortium, joint
venture, or other form of enterprise.
(2) Facility.--The term ''facility'' means any real
property, including any building, improvement, or appurtenance.
(3) Gross negligence.--The term ''gross negligence'' means
voluntary and conscious conduct by a person with knowledge (at
the time of the conduct) that the conduct is likely to be
harmful to the health or well-being of another person.
(4) Intentional misconduct.--The term ''intentional
misconduct'' means conduct by a person with knowledge (at the
time of the conduct) that the conduct is harmful to the health
or well-being of another person.
(5) Nonprofit organization.--The term ''nonprofit
organization'' means--
(A) any organization described in section 501(c)(3)
of the Internal Revenue Code of 1986 and exempt from
tax under section 501(a) of such Code; or
(B) any not-for-profit organization organized and
conducted for public benefit and operated primarily for
charitable, civic, educational, religious, welfare, or
health purposes.
(6) State.--The term ''State'' means each of the several
States, the District of Columbia, the Commonwealth of Puerto
Rico, the Virgin Islands, Guam, American Samoa, the Northern
Mariana Islands, any other territory or possession of the
United States, or any political subdivision of any such State,
territory, or possession.
(b) Limitation on Liability.--
(1) In general.--Subject to subsection (c), a business
entity shall not be subject to civil liability relating to any
injury or death occurring at a facility of the business entity
in connection with a use of such facility by a nonprofit
organization if--
(A) the use occurs outside of the scope of business
of the business entity;
(B) such injury or death occurs during a period
that such facility is used by the nonprofit
organization; and
(C) the business entity authorized the use of such
facility by the nonprofit organization.
(2) Application.--This subsection shall apply--
(A) with respect to civil liability under Federal
and State law; and
(B) regardless of whether a nonprofit organization
pays for the use of a facility.
(c) Exception for Liability.--Subsection (b) shall not apply to an
injury or death that results from an act or omission of a business
entity that constitutes gross negligence or intentional misconduct,
including any misconduct that--
(1) constitutes a crime of violence (as that term is
defined in section 16 of title 18, United States Code) or act
of international terrorism (as that term is defined in section
2331 of title 18) for which the defendant has been convicted in
any court;
(2) constitutes a hate crime (as that term is used in the
Hate Crime Statistics Act (28 U.S.C. 534 note));
(3) involves a sexual offense, as defined by applicable
State law, for which the defendant has been convicted in any
court; or
(4) involves misconduct for which the defendant has been
found to have violated a Federal or State civil rights law.
(d) Superseding Provision.--
(1) In general.--Subject to paragraph (2) and subsection
(e), this Act preempts the laws of any State to the extent that
such laws are inconsistent with this Act, except that this Act
shall not preempt any State law that provides additional
protection from liability for a business entity for an injury
or death with respect to which conditions under subparagraphs
(A) through (C) of subsection (b)(1) apply.
(2) Limitation.--Nothing in this Act shall be construed to
supersede any Federal or State health or safety law.
(e) Election of State Regarding Nonapplicability.--This Act shall
not apply to any civil action in a State court against a business
entity in which all parties are citizens of the State if such State
enacts a statute--
(1) citing the authority of this subsection;
(2) declaring the election of such State that this Act
shall not apply to such civil action in the State; and
(3) containing no other provision.
Solution: Shields a business entity from civil liability relating to any injury or death occurring at a facility of that entity in connection with a use of such facility by a nonprofit organization if: (1) the use occurs outside the scope of business of the business entity; (2) such injury or death occurs during a period that such facility is used by such organization; and (3) the business entity authorized the use of such facility by the organization.
Makes this Act inapplicable to an injury or death that results from an act or omission of a business entity that constitutes gross negligence or intentional misconduct, including misconduct that: (1) constitutes a hate crime or a crime of violence or act of international terrorism for which the defendant has been convicted in any court; or (2) involves a sexual offense for which the defendant has been convicted in any court or misconduct for which the defendant has been found to have violated a Federal or State civil rights law.
Preempts State laws to the extent that such laws are inconsistent with this Act, except State law that provides additional protection from liability. Specifies that this Act shall not be construed to supersede any Federal or State health or safety law.
Makes this Act inapplicable to any civil action in a State court against a business entity in which all parties are citizens of the State if such State, citing this Act's authority and containing no other provision, enacts a statute declaring the State's election that this Act shall not apply to such action in the State.
Reason: This Bill focuses on shielding business entities from civil liability relating to an injury or death depending on the conditions of injury, hence the generated summary is correct.

Now, solve this instance: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Lung Cancer Mortality Reduction Act
of 2011''.

SEC. 2. FINDINGS.

Congress makes the following findings:
(1) Lung cancer is the leading cause of cancer death for
both men and women, accounting for 28 percent of all cancer
deaths.
(2) The National Cancer Institute estimates that in 2010,
there were 222,520 new diagnoses of lung cancer and 157,300
deaths attributed to the disease.
(3) According to projections published in the Journal of
Clinical Oncology in 2009, between 2010 and 2030, the incidence
of lung cancer will increase by 46 percent for women and by 58
percent for men. The increase in the incidence of lung cancer
among minority communities during that time period will range
from 74 percent to 191 percent.
(4) Lung cancer causes more deaths annually than the next 4
leading causes of cancer deaths, colon cancer, breast cancer,
prostate cancer, and pancreatic cancer, combined.
(5) The 5-year survival rate for lung cancer is only 15
percent, while the 5-year survival rate for breast cancer is 89
percent, for prostate cancer 99 percent, and for colon cancer
65 percent. Yet in research dollars per death, lung cancer is
the least funded of the major cancers.
(6) In 2001, the Lung Cancer Progress Review Group of the
National Cancer Institute stated that funding for lung cancer
research was ''far below the levels characterized for other
common malignancies and far out of proportion to its massive
health impact'' and it gave the ''highest priority'' to the
creation of an integrated multidisciplinary, multi-
institutional research program. No comprehensive plan has been
developed.
(7) While smoking is the leading risk factor for lung
cancer, the President's National Cancer Advisory Board Report
of 2010 identified radon as the second leading cause of lung
cancer and listed 15 other environmental contaminants strongly
association with lung cancer, and there is accumulating
evidence that hormonal and genetic factors may influence the
onset.
(8) Lung cancer is the most stigmatized of all the cancers
and the only cancer blamed on patients, whether they smoked or
not.
(9) Nearly 20 percent of lung cancer patients have never
smoked. Sixty percent of individuals diagnosed with lung cancer
are former smokers who quit, often decades ago.
(10) Lung cancer in men and women who never smoked is the
sixth leading cause of cancer death. Of individuals diagnosed
with lung cancer who have never smoked, /3\ of are women.
(11) Lung cancer is the leading cause of cancer death in
the overall population and in every major ethnic grouping,
including White, African-American, Hispanic, Asian and Pacific
Islander, American Indian, and Alaskan Native, with an even
disproportionately higher impact on African-American males that
has not been addressed.
(12) Military personnel, veterans, and munitions workers
exposed to carcinogens such as Agent Orange, crystalline forms
of silica, arsenic, uranium, beryllium, and battlefield fuel
emissions have increased risk for lung cancer.
(13) Only 16 percent of lung cancer is being diagnosed at
an early stage and there were no targets for the early
detection or treatment of lung cancer included in the
Department of Health and Human Services's ''Healthy People
2010'' or ''Healthy People 2020''.
(14) An actuarial analysis carried out by Milliman Inc. and
published in Population Health Management Journal in 2009
indicated that early detection of lung cancer could save more
than 70,000 lives a year in the United States.
(15) A National Cancer Institute study in 2009 indicated
that while the value of life lost to lung cancer will exceed
$433,000,000,000 a year by 2020, a 4-percent annual decline in
lung cancer mortality would reduce that amount by more than
half.
(16) In 2010, the National Cancer Institute released
initial results from the National Lung Screening Trial, a
large-scale randomized national trial that compared the effect
of low-dose helical computed tomography (''CT'') and a standard
chest x-ray on lung cancer mortality. The study found 20
percent fewer lung cancer deaths among study participants
screened with the CT scan.

SEC. 3. SENSE OF THE CONGRESS CONCERNING INVESTMENT IN LUNG CANCER
RESEARCH.

It is the sense of the Congress that--
(1) lung cancer mortality reduction should be made a
national public health priority; and
(2) a comprehensive mortality reduction program coordinated
by the Secretary of Health and Human Services is justified and
necessary to adequately address all aspects of lung cancer and
reduce lung cancer mortality among current smokers, former
smokers, and non-smokers.

SEC. 4. LUNG CANCER MORTALITY REDUCTION PROGRAM.

Part P of title III of the Public Health Service Act (42 U.S.C.
280g et seq.) is amended by adding at the end the following:

''SEC. 399V-6. LUNG CANCER MORTALITY REDUCTION PROGRAM.

''(a) In General.--Not later than 180 days after the date of
enactment of the Lung Cancer Mortality Reduction Act of 2011, the
Secretary, in consultation with the Secretary of Defense, the Secretary
of Veterans Affairs, the Director of the National Institutes of Health,
the Director of the Centers for Disease Control and Prevention, the
Commissioner of Food and Drugs, the Administrator of the Centers for
Medicare & Medicaid Services, the Director of the National Center on
Minority Health and Health Disparities, and other members of the Lung
Cancer Advisory Board established under section 7 of the Lung Cancer
Mortality Reduction Act of 2011, shall implement a comprehensive
program to achieve a 50-percent reduction in the mortality rate of lung
cancer by 2020.
''(b) Requirements.--The program implemented under subsection (a)
shall include at least the following:
''(1) With respect to the National Institutes of Health--
''(A) a strategic review and prioritization by the
National Cancer Institute of research grants to achieve
the goal of the lung cancer mortality reduction program
in reducing lung cancer mortality;
''(B) the provision of funds to enable the Airway
Biology and Disease Branch of the National Heart, Lung,
and Blood Institute to expand its research programs to
include predispositions to lung cancer, the
interrelationship between lung cancer and other
pulmonary and cardiac disease, and the diagnosis and
treatment of these interrelationships;
''(C) the provision of funds to enable the National
Institute of Biomedical Imaging and Bioengineering to
expedite the development of screening, diagnostic,
surgical, treatment, and drug testing innovations to
facilitate the potential of imaging as a biomarker and
reduce lung cancer mortality, such as through expansion
of the Quantum Grant Program and Image-Guided
Interventions programs of the National Institute of
Biomedical Imaging and Bioengineering;
''(D) the provision of funds to enable the National
Institute of Environmental Health Sciences to implement
research programs relative to lung cancer incidence;
and
''(E) the provision of funds to enable the National
Institute on Minority Health and Health Disparities to
collaborate on prevention, early detection, and disease
management research, and to conduct outreach programs
in order to address the impact of lung cancer on
minority populations.
''(2) With respect to the Food and Drug Administration, the
provision of funds to enable the Center for Devices and
Radiologic Health to--
''(A) establish quality standards and guidelines
for hospitals, outpatient departments, clinics,
radiology practices, mobile units, physician offices,
or other facilities that conduct computed tomography
screening for lung cancer;
''(B) provide for the expedited revision of
standards and guidelines, as required to accommodate
technological advances in imaging; and
''(C) conduct an annual random sample survey to
review compliance and evaluate dose and accuracy
performance.
''(3) With respect to the Centers for Disease Control and
Prevention--
''(A) the provision of funds to establish a Lung
Cancer Early Detection Program that provides low-
income, uninsured, and underserved populations that are
at high risk for lung cancer access to early detection
services;
''(B) the provision of funds to enable the National
Institute for Occupational Safety and Health to conduct
research on environmental contaminants strongly
associated with lung cancer in the workplace and
implement measures to reduce lung cancer risk and
provide for an early detection program; and
''(C) a requirement that State, tribal, and
territorial plans developed under the National
Comprehensive Cancer Control Program include lung
cancer mortality reduction measures commensurate with
the public health impact of lung cancer.
''(4) With respect to the Agency for Healthcare Research
and Quality, the annual review of lung cancer early detection
methods, diagnostic and treatment protocols, and the issuance
of updated guidelines.
''(5) The cooperation and coordination of all programs for
women, minorities, and health disparities within the Department
of Health and Human Services to ensure that all aspects of the
Lung Cancer Mortality Reduction Program adequately address the
burden of lung cancer on women and minority, rural, and
underserved populations.
''(6) The cooperation and coordination of all tobacco
control and cessation programs within agencies of the
Department of Health and Human Services to achieve the goals of
the Lung Cancer Mortality Reduction Program with particular
emphasis on the coordination of drug and other cessation
treatments with early detection protocols.''.

SEC. 5. DEPARTMENT OF DEFENSE AND THE DEPARTMENT OF VETERANS AFFAIRS.

The Secretary of Defense and the Secretary of Veterans Affairs
shall coordinate with the Secretary of Health and Human Services--
(1) in developing the Lung Cancer Mortality Reduction
Program under section 399V-6 of the Public Health Service Act,
as added by section 4;
(2) in implementing the demonstration project under section
6 within the Department of Defense and the Department of
Veterans Affairs with respect to military personnel and
veterans whose smoking history and exposure to carcinogens
during active duty service has increased their risk for lung
cancer; and
(3) in implementing coordinated care programs for military
personnel and veterans diagnosed with lung cancer.

SEC. 6. LUNG CANCER SCREENING DEMONSTRATION PROJECT.

(a) Sense of the Congress.--It is the sense of the Congress that a
national computed tomography lung cancer screening demonstration
project should be carried out expeditiously in order to assess the
public health infrastructure needs and to develop the most effective,
safe, equitable, and efficient process that will maximize the public
health benefits of screening.
(b) Demonstration Project in General.--Not later than 1 year after
the date of enactment of this Act, the Secretary of Health and Human
Services (referred to in this Act as the ''Secretary''), in
consultation with the Secretary of Defense, the Secretary of Veterans
Affairs, the Director of the National Institutes of Health, the
Director of the Centers for Disease Control and Prevention, the
Commissioner of Food and Drugs, the Administrator of the Centers for
Medicare & Medicaid Services, and the other members of the Lung Cancer
Advisory Board established under section 7 of the Lung Cancer Mortality
Reduction Act of 2011, shall establish a demonstration project, to be
known as the Lung Cancer Computed Tomography Screening and Treatment
Demonstration Project (referred to in this section as the
''demonstration project'').
(c) Program Requirements.--The Secretary shall ensure that the
demonstration project--
(1) identifies the optimal risk populations that would
benefit from screening;
(2) develops the most effective, safe, equitable and cost-
efficient process for screening and early disease management;
(3) allows for continuous improvements in quality controls
for the process; and
(4) serves as a model for the integration of health
information technology and the concept of a rapid learning into
the health care system.
(d) Participation.--The Secretary shall select not less than 5
National Cancer Institute Centers, 5 Department of Defense Medical
Treatment Centers, 5 sites within the Veterans Affairs Healthcare
Network, 5 International Early Lung Cancer Action Program sites, 10
community health centers for minority and underserved populations, and
additional sites as the Secretary determines appropriate, as sites to
carry out the demonstration project described under this section.
(e) Quality Standards and Guidelines for Licensing of Tomography
Screening Facilities.--The Secretary shall establish quality standards
and guidelines for the licensing of hospitals, outpatient departments,
clinics, radiology practices, mobile units, physician offices, or other
facilities that conduct computed tomography screening for lung cancer
through the demonstration project, that will require the establishment
and maintenance of a quality assurance and quality control program at
each such facility that is adequate and appropriate to ensure the
reliability, clarity, and accuracy of the equipment and interpretation
of the screening scan and set appropriate standards to control the
levels of radiation dose.
(f) Timeframe.--The Secretary shall conduct the demonstration
project under this section for a 5-year period.
(g) Report.--Not later than 180 days after the date of enactment of
this Act, the Secretary shall submit a report to Congress on the
projected cost of the demonstration project, and shall submit annual
reports to Congress thereafter on the progress of the demonstration
project and preliminary findings.

SEC. 7. LUNG CANCER ADVISORY BOARD.

(a) In General.--The Secretary of Health and Human Services shall
establish a Lung Cancer Advisory Board (referred to in this section as
the ''Board'') to monitor the programs established under this Act (and
the amendments made by this Act), and provide annual reports to
Congress concerning benchmarks, expenditures, lung cancer statistics,
and the public health impact of such programs.
(b) Composition.--The Board shall be composed of--
(1) the Secretary of Health and Human Services;
(2) the Secretary of Defense;
(3) the Secretary of Veterans Affairs;
(4) the Director of the Occupational Safety and Health
Administration;
(5) the Director of the National Institute of Standards and
Technology; and
(6) one representative each from the fields of clinical
medicine focused on lung cancer, lung cancer research,
radiology, imaging research, drug development, minority health
advocacy, veterans service organizations, lung cancer advocacy,
and occupational medicine to be appointed by the Secretary of
Health and Human Services.

SEC. 8. AUTHORIZATION OF APPROPRIATIONS.

To carry out this Act (and the amendments made by this Act), there
are authorized to be appropriated such sums as may be necessary for
each of fiscal years 2012 through 2016.
Student:
Lung Cancer Mortality Reduction Act of 2011- Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to implement a comprehensive program to achieve a 50% reduction in the mortality rate of lung cancer by 2020. Requires the program to include initiatives throughout HHS, including: (1) a strategic review and prioritization by the National Cancer Institute of research grants; (2) the establishment by the Food and Drug Administration (FDA) of quality standards and guidelines for facilities that conduct computed tomography screening for lung cancer; and (3) the provision of funds to the Centers for Disease Control and Prevention (CDC) to establish a Lung Cancer Early Detection Program that provides low-income, uninsured, and underserved populations that are at high risk for lung cancer access to early detection services.

Requires the Secretary of Defense (DOD) and the Secretary of Veterans Affairs (VA) to coordinate with the Secretary of HHS in implementing this Act and implementing coordinated care programs for military personnel and veterans diagnosed with lung cancer.

Requires the Secretary of HHS to establish: (1) the Lung Cancer Computed Tomography Screening and Treatment Demonstration Project; and (2) the Lung Cancer Advisory Board to monitor the programs established under this Act.